https://smallinsight.com/corporate-analysis/samsungs-record-107-billion-profit-semiconductor-division-drives/ SmallInsight en 2026-10-29T10:28:13.000Z Samsung's Record $107 Billion Profit: Semiconductor Division Drives 99% of Earnings https://smallinsight.com/corporate-analysis/danah-data-unveils-revolutionary-ai-health-management/ SmallInsight en 2026-10-29T09:38:05.000Z Danah Data Unveils Revolutionary AI Health Management: 'Comprehensive Diagnostic-Driven AI Care' Combines Biometric Age Analysis and AI Consultancy https://smallinsight.com/editors-pick/renewable-energys-record-run-faces-5-year-slump-transmission/ SmallInsight en 2026-10-29T09:04:27.000Z Renewable Energy's Record Run Faces 5-Year Slump: Transmission Grid Constraints Curb Growth https://smallinsight.com/corporate-analysis/daeung-pharm-unveils-ai-smart-hospital-at-mars-2026-a/ SmallInsight en 2026-10-29T08:43:21.000Z Daeung Pharm Unveils AI Smart Hospital at MARS 2026: A Comprehensive View from Wards to Diagnostics, Rehabilitation, and Treatment https://smallinsight.com/market-briefing/wall-street-bets-on-december-hike-despite-feds-pause-divergent/ SmallInsight en 2026-10-29T07:59:34.000Z Wall Street Bets on December Hike Despite Fed's Pause, Divergent Views on 2023 Rate Path https://smallinsight.com/corporate-analysis/hanol-biopharmas-strong-drug-sales-drive-q3-revenue-to-krw-124/ SmallInsight en 2026-10-28T17:27:06.000Z Hanol Biopharma's Strong Drug Sales Drive Q3 Revenue to KRW 1.24 Trillion https://smallinsight.com/stock-news/nationwide-consumer-festival-kicks-off-from-beef-to-electronics/ SmallInsight en 2026-10-28T17:07:19.000Z Nationwide Consumer Festival Kicks Off: From Beef to Electronics, a Week of Deals Starts Friday https://smallinsight.com/corporate-analysis/hd-hyundai-electric-expands-production-riding-high-on-surging/ SmallInsight en 2026-10-28T16:51:27.000Z HD Hyundai Electric Expands Production, Riding High on Surging Orders https://smallinsight.com/market-briefing/kospi-recovers-to-6000-level-net-purchase-by-foreign-investors/ SmallInsight en 2026-10-28T16:32:04.000Z [KRX deadline | October 28] KOSPI recovers to 6000 level... Net purchase by Foreign Investors and institutions of KRW 1.7835 trillion https://smallinsight.com/corporate-analysis/dae-woong-pharmas-enblo-doubles-down-on-appetite-control-showing/ SmallInsight en 2026-10-28T15:55:58.000Z Dae Woong Pharma's 'Enblo' Doubles Down on Appetite Control, Showing Promise for Metabolic Disorders Beyond Diabetes https://smallinsight.com/market-briefing/ai-bears-silenced-by-niks-stellar-performance/ SmallInsight en 2026-10-28T15:18:00.000Z [Seoul Market Wrap] AI Bears Silenced by 'Niks' Stellar Performance https://smallinsight.com/corporate-analysis/gm-joins-hybrid-race-intensifying-suv-battle-with-hyundai-and/ SmallInsight en 2026-10-28T14:15:31.000Z GM Joins Hybrid Race, Intensifying SUV Battle with Hyundai and Kia in the U.S. https://smallinsight.com/stock-news/nvidias-strategic-move-boosting-ai-inference-efficiency-through/ SmallInsight en 2026-10-28T13:57:20.000Z Nvidia's Strategic Move: Boosting AI Inference Efficiency Through Investment and Software https://smallinsight.com/corporate-analysis/sk-hynixs-profits-soar-as-memory-chip-demand-booms-operating/ SmallInsight en 2026-10-28T11:32:04.000Z SK Hynix's Profits Soar as Memory Chip Demand Booms, Operating Margin Nears 80%. https://smallinsight.com/corporate-analysis/altheogens-eu-early-breast-cancer-approval-boosts-sc/ SmallInsight en 2026-10-28T09:22:28.000Z Altheogen's EU Early Breast Cancer Approval Boosts SC Commercialization Prospects https://smallinsight.com/stock-news/ai-investments-boom-as-big-tech-reshapes-the-employment/ SmallInsight en 2026-10-28T08:59:27.000Z AI Investments Boom as Big Tech Reshapes the Employment Landscape, Downsizing Traditional Workforce https://smallinsight.com/stock-news/will-im-young-woongs-new-venture-rewrite-box-office-history/ SmallInsight en 2026-10-28T08:53:40.000Z Will Im Young-Woong's New Venture Rewrite Box Office History After $100 Million Success? https://smallinsight.com/corporate-analysis/hanall-biopharma-aims-for-2028-graves-disease-treatment-launch/ SmallInsight en 2026-10-28T08:53:40.000Z HanAll Biopharma Aims for 2028 Graves' Disease Treatment Launch with Aimereprobat https://smallinsight.com/market-briefing/ai-stocks-turn-the-tables-buying-switch-flips-back-on/ SmallInsight en 2026-10-28T06:53:59.000Z [Seoul Pre-Market Brief] AI Stocks Turn the Tables, Buying Switch Flips Back On https://smallinsight.com/market-briefing/nasdaq-soars-118-on-semiconductor-strength-boeing-plunges-1069/ SmallInsight en 2026-10-28T06:19:25.000Z Nasdaq Soars 1.18% on Semiconductor Strength; Boeing Plunges 10.69% https://smallinsight.com/market-briefing/october-27th-a-bleak-day-as-antoic-bleeds-under-heavy-selling/ SmallInsight en 2026-10-27T15:15:24.000Z [Seoul Market Wrap] October 27th: A Bleak Day as Antoic Bleeds Under Heavy Selling https://smallinsight.com/corporate-analysis/aimed-bios-adc-leads-the-way-with-first-dosing-set-to-receive/ SmallInsight en 2026-10-27T14:34:59.000Z Aimed Bio's ADC Leads the Way with First Dosing, Set to Receive Subsequent Milestone Payments from Boehringer https://smallinsight.com/corporate-analysis/hd-modern-marine-solutions-suffers-relentless-selloff-analysts/ SmallInsight en 2026-10-27T14:23:04.000Z HD Modern Marine Solutions Suffers Relentless Selloff, Analysts Slash Price Targets https://smallinsight.com/stock-news/will-jeon-do-yeon-knock-on-the-oscar-door-americas-eyes-on/ SmallInsight en 2026-10-27T11:38:17.000Z Will Jeon Do-yeon Knock on the Oscar Door? America's Eyes on 'Possible Love' https://smallinsight.com/corporate-analysis/hlbs-rivoceranib-delivers-118-month-pfs-in-rare-cancer-prepares/ SmallInsight en 2026-10-27T10:38:00.000Z [ESMO 2026 Analysis] HLB's Rivoceranib Delivers 11.8-Month PFS in Rare Cancer; Prepares for U.S. Launch of Lifiting